{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:09:34Z","timestamp":1775232574874,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.diagmicrobio.2005.08.018","type":"journal-article","created":{"date-parts":[[2006,1,10]],"date-time":"2006-01-10T12:08:03Z","timestamp":1136894883000},"page":"135-139","source":"Crossref","is-referenced-by-count":43,"title":["In vitro activity of \u03b2-lactam and non\u2013\u03b2-lactam antibiotics in extended-spectrum \u03b2-lactamase\u2013producing clinical isolates of Escherichia coli"],"prefix":"10.1016","volume":"54","author":[{"given":"Antonio Sorl\u00f3zano","family":"Puerto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Guti\u00e9rrez","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan de Dios Luna","family":"del Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9 Soto","family":"Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo Pi\u00e9drola","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib1","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/jac\/42.4.415","article-title":"Extended-spectrum \u03b2-lactamases: The role of inhibitors in therapy","volume":"42","author":"Amyes","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum \u03b2-lactamases in the 21st century: Characterization, epidemiology, and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib3","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/AAC.36.11.2536","article-title":"Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum \u03b2-lactamases","volume":"36","author":"Fernandez-Rodriguez","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0732-8893(99)00117-0","article-title":"Screening and confirmatory testing for extended spectrum \u03b2-lactamases (ESBL) in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca clinical isolates","volume":"36","author":"Hadziyannis","year":"2000","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib5","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1128\/AAC.49.5.2122-2125.2005","article-title":"Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum \u03b2-lactamases in Spain","volume":"49","author":"Hernandez","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1157\/13042863","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals (GEIH-BLEE Project 2002)","volume":"21","author":"Hernandez","year":"2003","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0732-8893(02)00358-9","article-title":"Potency and antimicrobial spectrum update for piperacillin-tazobactam 2000: Emphasis on its activity against resistant organisms populations and generally untested species causing community-acquired respiratory tract infections","volume":"43","author":"Johnson","year":"2002","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/jac\/37.1.203","article-title":"Treatment failure due to extended-spectrum \u03b2-lactamase","volume":"37","author":"Karas","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/319757","article-title":"Extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes","volume":"32","author":"Lautenbach","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib10","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/322667","article-title":"Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum \u03b2-lactamase producing Escherichia coli and Klebsiella pneumoniae","volume":"33","author":"Lautenbach","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/AAC.48.1.224-228.2004","article-title":"Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: A case-control study","volume":"48","author":"Lee","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib12","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1128\/JCM.39.8.2964-2966.2001","article-title":"Evaluation of VITEK 2 rapid identification and susceptibility testing system against gram-negative clinical isolates","volume":"39","author":"Ling","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jac\/49.2.289","article-title":"Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests","volume":"49","author":"Livermore","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib14","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1128\/AAC.40.2.342","article-title":"In vivo selection of porin deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum cephalosporins","volume":"40","author":"Martinez-Martinez","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(97)07322-4","article-title":"Quinolone resistance from a transferable plasmid","volume":"351","author":"Martinez-Martinez","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib16","series-title":"Performance standards for antimicrobial susceptibility testing","author":"National Committee for Clinical Laboratory Standards","year":"2004"},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0213-005X(02)72796-1","article-title":"Interpretive reading of the antibiogram of enterobacteria","volume":"20","author":"Navarro","year":"2002","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1157\/13059048","article-title":"Quinolone use and resistance","volume":"22","author":"Oteo","year":"2004","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/313719","article-title":"Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum \u03b2-lactamase production in Klebsiella pneumoniae isolates causing bacteremia","volume":"30","author":"Paterson","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib20","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","article-title":"Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum \u03b2-lactamases: Implications for the clinical microbiology laboratory","volume":"39","author":"Paterson","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/infdis\/173.1.151","article-title":"Molecular genetics of resistance to both ceftazidime and \u03b2-lactam\u2013\u03b2-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to \u03b2-lactam therapy","volume":"173","author":"Rice","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib22","first-page":"227","article-title":"A preliminary study on the presence of extended-spectrum beta-lactamases (ESBL) in clinical isolates of Escherichia coli in Granada (Spain)","volume":"54","author":"Sorlozano","year":"2004","journal-title":"Ann. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.diagmicrobio.2004.06.003","article-title":"High incidence of extended-spectrum \u03b2-lactamases among outpatient clinical isolates of Escherichia coli: a phenotypic assessment of NCCLS guidelines and a commercial method","volume":"50","author":"Sorlozano","year":"2004","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.diagmicrobio.2004.11.001","article-title":"Acceptable performance of VITEK 2 system to detect extended-spectrum beta-lactamases in clinical isolates of Escherichia coli: A comparative study of phenotypic commercial methods and NCCLS guidelines","volume":"51","author":"Sorlozano","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/AAC.46.1.196-202.2002","article-title":"Occurrence of extended-spectrum \u03b2-lactamases in members of the family Enterobacteriaceae in Italy: Implications for resistance to \u03b2-lactams and other antimicrobial drugs","volume":"46","author":"Spanu","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib26","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/AAC.45.12.3548-3554.2001","article-title":"Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum \u03b2-lactamase producing Enterobacteriaceae","volume":"45","author":"Thomson","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.08.018_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1086\/320182","article-title":"Variations in the prevalence of strains expressing an extended-spectrum \u03b2-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western, Pacific Region","volume":"32","author":"Winokur","year":"2001","journal-title":"Clin. Infect. Dis."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305002312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305002312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,14]],"date-time":"2019-04-14T05:19:08Z","timestamp":1555219148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889305002312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0732889305002312"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2005.08.018","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}